US Patent 11572388 Chimeric polypeptides and uses thereof
Patent 11572388 was granted and assigned to Kite Pharma, Inc. on February, 2023 by the United States Patent and Trademark Office.
All edits
Edits on 29 Apr, 2023
Golden AI
Infobox
Is a
Patent Applicant
Current Assignee
Patent Jurisdiction
Patent Number
115723880
Date of Patent
February 7, 2023
0Patent Application Number
159297370
Date Filed
May 19, 2020
0Patent Primary Examiner
Edits on 8 Feb, 2023
Golden AI
Edits made to:
Infobox (+29 properties)
Article (+450 characters)
US Patent 11572388 Chimeric polypeptides and uses thereof
Article
The invention provides novel peptides (e.g., linkers) and polypeptide compositions comprising the linkers (e.g., fusion proteins) and methods of using the polypeptide compositions. Peptides (e.g., linkers) are useful as tags and for engineering fusion proteins (e.g., antigen binding molecules, scFv). Polypeptide linkers described herein facilitate flexibility of linked peptides allowing for proper folding, conformation and reduced immunogenicity.
Infobox
Is a
Patent Applicant
Current Assignee
Patent Jurisdiction
Patent Number
115723880
Date of Patent
February 7, 2023
0Patent Application Number
159297370
Date Filed
May 19, 2020
0Patent Primary Examiner
Find more entities like US Patent 11572388 Chimeric polypeptides and uses thereof
Use the Golden Query Tool to find similar entities by any field in the Knowledge Graph, including industry, location, and more.
